Manufacturing issues lead to shortage of popular impetigo remedy The TGA is advising health professionals and consumers that there is a shortage of Bactroban (mupirocin) 20 mg/g ointment tubes. Bactroban 20 mg/g ointment is used for the topical treatment of mild impetigo. The product's sponsor, GlaxoSmithKline Australia, has advised the TGA that the shortage is
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.